230 related articles for article (PubMed ID: 31190860)
1. Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis.
Wu Q; Zhang B; Sun Y; Xu R; Hu X; Ren S; Ma Q; Chen C; Shu J; Qi F; He T; Wang W; Wang Z
Onco Targets Ther; 2019; 12():3545-3563. PubMed ID: 31190860
[No Abstract] [Full Text] [Related]
2. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
3. Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data.
Li C; Wan Y; Deng W; Fei F; Wang L; Qi F; Zheng Z
Open Med (Wars); 2022; 17(1):96-112. PubMed ID: 35028418
[TBL] [Abstract][Full Text] [Related]
4. Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis.
Ni M; Liu X; Wu J; Zhang D; Tian J; Wang T; Liu S; Meng Z; Wang K; Duan X; Zhou W; Zhang X
Front Genet; 2018; 9():469. PubMed ID: 30369945
[No Abstract] [Full Text] [Related]
5. Identification of key candidate tumor biomarkers in non-small-cell lung cancer by
Chen W; Zhu S; Zhang Y; Xiao J; Tian D
Oncol Lett; 2020 Jan; 19(1):1008-1016. PubMed ID: 31897214
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
7. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
8. The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation.
Yin Y; Li D; He M; Wang J
Transl Cancer Res; 2022 Aug; 11(8):2622-2635. PubMed ID: 36093542
[TBL] [Abstract][Full Text] [Related]
9. The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data.
Zhang B; Wu Q; Wang Z; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qin L; Ma Q; Zhou YL
Mol Genet Genomic Med; 2019 May; 7(5):e607. PubMed ID: 30793530
[TBL] [Abstract][Full Text] [Related]
10. GOLM1 predicts poor prognosis of patients with NSCLC and is associated with the proliferation and chemo-sensitivity of cisplatin in NSCLC cells: bioinformatics analysis and laboratory validation.
Zhao M; Li X; Chen X
J Bioenerg Biomembr; 2021 Apr; 53(2):177-189. PubMed ID: 33538941
[TBL] [Abstract][Full Text] [Related]
11. Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis.
Zeng Y; Li N; Chen R; Liu W; Chen T; Zhu J; Zeng M; Cheng J; Huang J
Transl Cancer Res; 2020 Nov; 9(11):7149-7164. PubMed ID: 35117319
[TBL] [Abstract][Full Text] [Related]
12. Exploration of estrogen receptor-associated hub genes and potential molecular mechanisms in non-smoking females with lung adenocarcinoma using integrated bioinformatics analysis.
Wang H; Zhang Z; Xu K; Wei S; Li L; Wang L
Oncol Lett; 2019 Nov; 18(5):4605-4612. PubMed ID: 31611968
[TBL] [Abstract][Full Text] [Related]
13. Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
Wang W; Wang S; Pan L
Exp Ther Med; 2020 Oct; 20(4):3720-3732. PubMed ID: 32855723
[TBL] [Abstract][Full Text] [Related]
14. Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis.
Cui S; Lou S; Feng J; Tang X; Xiao X; Huang R; Guo W; Zhou Y; Huang F
Transl Cancer Res; 2022 Apr; 11(4):710-724. PubMed ID: 35571642
[TBL] [Abstract][Full Text] [Related]
15. Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis.
Yu L; Liang X; Wang J; Ding G; Tang J; Xue J; He X; Ge J; Jin X; Yang Z; Li X; Yao H; Yin H; Liu W; Yin S; Sun B; Sheng J
Genet Res (Camb); 2023; 2023():6782732. PubMed ID: 36688087
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray.
Alshabi AM; ; Shaikh IA; Vastrad C
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31311202
[No Abstract] [Full Text] [Related]
17. Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.
Xue H; Sun Z; Wu W; Du D; Liao S
Cancer Manag Res; 2021; 13():117-131. PubMed ID: 33447084
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy.
Wei M; Bai X; Dong Q
Transl Cancer Res; 2022 Jun; 11(6):1630-1643. PubMed ID: 35836518
[TBL] [Abstract][Full Text] [Related]
19. The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data.
Zhang B; Wu Q; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Wang Z; Zhou YL
J Cell Biochem; 2019 Sep; 120(9):15106-15118. PubMed ID: 31020692
[TBL] [Abstract][Full Text] [Related]
20. Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis.
Mengyan X; Kun D; Xinming J; Yutian W; Yongqian S
Front Pharmacol; 2022; 13():997842. PubMed ID: 36176446
[No Abstract] [Full Text] [Related]
[Next] [New Search]